CLOSE X

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE1654.553.1 (+0.19 %)
PREV CLOSE ( ) 1651.45
OPEN PRICE ( ) 1638.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 32230
TODAY'S LOW / HIGH ( )1638.00 1665.00
52 WK LOW / HIGH ( )1303 2029
NSE1655.105 (+0.3 %)
PREV CLOSE( ) 1650.10
OPEN PRICE ( ) 1642.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1655.10 (13)
VOLUME 499262
TODAY'S LOW / HIGH( ) 1640.50 1665.00
52 WK LOW / HIGH ( )1385.75 2030
GO
(Rs.in Million)
Particulars
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
9494.80
9634.90
10006.20
10044.00
Total Expenditure
7230.40
7089.80
7301.00
7240.30
PBIDT (Excl OI)
2264.40
2545.10
2705.20
2803.70
Other Income
144.80
80.00
99.50
58.90
Operating Profit
2409.20
2625.10
2804.70
2862.60
Interest
14.50
25.80
20.60
56.40
Exceptional Items
NA
NA
NA
NA
PBDT
2394.70
2599.30
2784.10
2806.20
Depreciation
464.40
419.40
418.80
407.80
Profit Before Tax
1930.30
2179.90
2365.30
2398.40
Tax
473.40
555.00
619.60
630.10
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1456.90
1624.90
1745.70
1768.30
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1456.90
1624.90
1745.70
1768.30
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1456.90
1624.90
1745.70
1768.30
Equity Capital
155.70
155.50
155.30
155.20
Face Value (IN RS)
1.00
1.00
1.00
1.00
Reserves
NA
NA
NA
NA
Calculated EPS
9.36
10.45
11.24
11.39
Calculated EPS (Annualised)
37.43
41.80
44.96
45.57
No of Public Share Holdings
81195689.00
72084064.00
71849744.00
71748394.00
% of Public Share Holdings
52.16
46.34
46.26
46.23
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
23.85
26.42
27.04
27.91
PBIDTM%
25.37
27.25
28.03
28.50
PBDTM%
25.22
26.98
27.82
27.94
PBTM%
20.33
22.63
23.64
23.88
PATM%
15.34
16.86
17.45
17.61
 
Notes
Notes
Notes
Notes
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors